Suppr超能文献

超声引导下肩峰下-三角肌下滑囊注射A型肉毒杆菌毒素治疗偏瘫肩痛的临床疗效:一项回顾性队列研究。

Clinical effectiveness of ultrasound guided subacromial-subdeltoid bursa injection of botulinum toxin type A in hemiplegic shoulder pain: A retrospective cohort study.

作者信息

Wu Tao, Song Hai-Xin, Li Yang Zheng, Ye Ye, Li Jian-Hua, Hu Xing Yue

机构信息

Department of Rehabilitation Medicine, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University.

Department of Neurology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hang Zhou, Zhe Jiang, PR China.

出版信息

Medicine (Baltimore). 2019 Nov;98(45):e17933. doi: 10.1097/MD.0000000000017933.

Abstract

Hemiplegic shoulder pain (HSP), which occurs in most patients with hemiplegia, causes considerable distress and worsens outcomes in rehabilitation. Although they have received the treatments such as anti-inflammatory drugs or physical therapy, many of the individuals remain suffering from shoulder pain 6 months after acute stroke event. In this retrospective study, we evaluated the effectiveness of ultrasound guided subacromial-subdeltoid (SASD) bursa injections with botulinum toxin type A (BoNT/A) compared to steroids for refractory HSP.The data were collected retrospectively by reviewing the patient's medical records and pain questionnaires in our rehabilitation center. In total, 38 patients who received ultrasound guided SASD bursa injection (BoNT/A group, n = 18; corticosteroid group, n = 20) were included. The pain visual analog scale (VAS) score at rest and during arm passive abduction, Fugl-Meyer score of upper limbs (F-M score) were evaluated before, 2, 4, 8, and 12 weeks after injection.Both 2 groups obtained a significant improvement of VAS score at rest or during arms passive abduction compared to baseline score (within group compare, P < .05). There were no significant differences of pain score improvement between two groups at week 2, 4, 8, and 12 after injection either at rest or during passive arm abduction (between 2 groups compare, P > .05). There were also no differences in results of the post treatment F-M score between 2 groups (between 2 groups compare, P > .05). Similarly, during the follow-up period no collateral effects were reported after BoNT/A injection.SASD bursa BoNT/A injection can substantially reduce the pain as corticosteroid in patients with HSP. BoNT/A injection could be a useful strategy for replacing steroids as a treatment for refractory HSP especially in the patients who cannot tolerate the steroids injection.

摘要

偏瘫肩痛(HSP)在大多数偏瘫患者中都会出现,会造成极大痛苦,并使康复效果恶化。尽管患者接受了诸如抗炎药物或物理治疗等治疗,但许多人在急性中风事件6个月后仍饱受肩痛困扰。在这项回顾性研究中,我们评估了与类固醇相比,超声引导下肩峰下-三角肌下(SASD)滑囊注射A型肉毒毒素(BoNT/A)治疗难治性HSP的有效性。通过查阅我们康复中心患者的病历和疼痛问卷,对数据进行回顾性收集。总共纳入了38例接受超声引导下SASD滑囊注射的患者(BoNT/A组,n = 18;皮质类固醇组,n = 20)。在注射前、注射后2周、4周、8周和12周,评估静息时和手臂被动外展时的疼痛视觉模拟量表(VAS)评分、上肢Fugl-Meyer评分(F-M评分)。与基线评分相比,两组在静息时或手臂被动外展时的VAS评分均有显著改善(组内比较,P < 0.05)。注射后第2周、4周、8周和12周,两组在静息时或被动手臂外展时的疼痛评分改善方面均无显著差异(两组间比较,P > 0.05)。两组治疗后的F-M评分结果也无差异(两组间比较,P > 0.05)。同样,在随访期间,未报告BoNT/A注射后的副作用。SASD滑囊BoNT/A注射在HSP患者中减轻疼痛的效果与皮质类固醇相当。BoNT/A注射可能是一种有用的策略,可替代类固醇用于治疗难治性HSP,尤其是那些不能耐受类固醇注射的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b8d/6855603/9f43c0d4ff90/medi-98-e17933-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验